Medistim ASA (OSL:MEDI)

Medistim ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	662.18	556.16	521.11	486.26	417.82	356.21
Revenue Growth (YoY)	22.21%	6.73%	7.17%	16.38%	17.30%	-0.20%
Cost of Revenue	125.63	113.68	112.28	106.49	97.11	76.58
Gross Profit	536.55	442.48	408.83	379.78	320.7	279.63
Selling, General & Admin	219.21	174.35	150.2	136.51	124.02	108.39
Other Operating Expenses	113.27	112.55	103.53	78.73	62.27	52.61
Operating Expenses	356.83	311.41	277.39	238.53	209.72	184.15
Operating Income	179.71	131.08	131.44	141.25	110.99	95.48
Interest Expense	-14.73	-	-	-0.12	-0.18	-0.15
Interest & Investment Income	2.61	4.57	3.28	0.92	0.02	0.01
Currency Exchange Gain (Loss)	-2.18	-1.63	0.93	3.06	-1.81	-3.48
Other Non Operating Income (Expenses)	21.89	0.23	-0.44	0.94	-0.24	-0.26
EBT Excluding Unusual Items	187.31	134.25	135.21	146.05	108.78	91.61
Other Unusual Items	-	-	-	-	5.29	-
Pretax Income	187.31	134.25	135.21	146.05	114.07	91.61
Income Tax Expense	44.88	30.41	31.39	32.08	23.17	22.22
Net Income	142.42	103.83	103.82	113.97	90.9	69.39
Net Income to Common	142.42	103.83	103.82	113.97	90.9	69.39
Net Income Growth	40.13%	0.01%	-8.91%	25.38%	31.00%	-1.31%
Shares Outstanding (Basic)	-	18	18	18	18	18
Shares Outstanding (Diluted)	-	18	18	18	18	18
Shares Change (YoY)	-	0.10%	0.10%	0.15%	0.07%	0.13%
EPS (Basic)	-	5.67	5.68	6.25	4.99	3.81
EPS (Diluted)	-	5.67	5.67	6.24	4.98	3.80
EPS Growth	-	-0.01%	-9.13%	25.30%	31.05%	-1.55%
Free Cash Flow	184.95	137.04	102.8	104.24	119.97	66.68
Free Cash Flow Per Share	-	7.48	5.62	5.70	6.57	3.66
Dividend Per Share	6.000	6.000	4.500	4.500	3.750	3.000
Dividend Growth	33.33%	33.33%	-	20.00%	25.00%	9.09%
Gross Margin	81.03%	79.56%	78.45%	78.10%	76.76%	78.50%
Operating Margin	27.14%	23.57%	25.22%	29.05%	26.56%	26.81%
Profit Margin	21.51%	18.67%	19.92%	23.44%	21.76%	19.48%
Free Cash Flow Margin	27.93%	24.64%	19.73%	21.44%	28.71%	18.72%
EBITDA	196.06	146.8	146.72	157.45	127.26	105.06
EBITDA Margin	29.61%	26.39%	28.16%	32.38%	30.46%	29.49%
D&A For EBITDA	16.35	15.72	15.27	16.2	16.27	9.57
EBIT	179.71	131.08	131.44	141.25	110.99	95.48
EBIT Margin	27.14%	23.57%	25.22%	29.05%	26.56%	26.81%
Effective Tax Rate	23.96%	22.66%	23.21%	21.96%	20.31%	24.25%
Revenue as Reported	562.6	562.6	526.36	491.94	427.28	363.13

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.